comparemela.com

Latest Breaking News On - Sino biological - Page 24 : comparemela.com

High-quality IL-7 cytokines and receptors for R&D : Get Quote, RFQ, Price or Buy

Interleukin-7 is a pivotal cytokine to B and T cell modulation and development. IL-7 is being targeted for its role in immunity and cancer pathogenesis, as such Sino Biological have produced a wide array of both IL-7 and its receptors.

Sino-biological-inc
Sino-biological
Il-7
Ytokines

IFN-γ: A therapeutic target for cancer therapy : Get Quote, RFQ, Price or Buy

IFN- is a cytokine crucial for the response against viruses and tumors, Sino Biological has a wide array of recombinant IFN- and its related receptor proteins which are perfect for R&D.

Sino-biological-inc
Sino-biological
Image-credit
Mouse-interferon-gamma
Rabbit-mab
Cancer-therapy
Afn

The Healthcare Technology Report's Top 100 Healthcare Technology Companies of 2022

New York, NY (PRWEB) August 03, 2022 The Healthcare Technology Report is pleased to announce The Top 100 Healthcare Technology Companies of 2022. The

New-york
United-states
Integra-lifesciences
Leica-biosystems
Intervenn-biosciences
Tosoh-bioscience
Ocimum-biosolutions
Edwards-lifesciences
Kaia-health
Omada-health
Sotera-health
Avalon-healthcare-solutions

Recombinant IL-13 receptors for inflammatory diseases and cancer : Get Quote, RFQ, Price or Buy

Sino Biological produces a wide range of IL-13 recombinant receptors for use in inflammatory disease and cancer research and development.

Sino-biological-inc
Sino-biological
Image-credit
Recombinant-human
Inflammatory-diseases
Dancer

Examining emerging targets within cancer immunotherapy

In this article, Sino Biological discusses emerging targets that are arising within the field of cancer immunotherapy, They also discuss the importance of cancer as a public health threat.

United-states
American
Innovent-biologics
Waterstone-hanxbio
Astellas-pharma
Alex-smith
Akesobio-biopharma
Mereo-biopharma
Bristol-myers-squibb
Sino-biological-inc-jul
Sino-biological-inc
Compugen

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.